Investigators used precision surveillance by combining genomic sequencing and conventional surveillance to delineate a nosocomial viral outbreak; they believe the findings of their study are applicable to a range of respiratory pathogens, including SARS-CoV-2.
During the 2 hours that the patient had been in the emergency department, she was examined by a physician once, 30 minutes after her arrival.
Patients with interstitial lung disease have an increased risk of severe disease and death associated with COVID-19.
Researchers conducted a prospective study to analyze the relationship between continued angiotensin-converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARB) use in the hospital and better clinical outcomes (ICU admission, morbidity, mortality).
The use of a PCR test via single nasopharyngeal swab to diagnose SARS-CoV-2 has value but also has demonstrated limitations.
A case of COVID-19 transmission in a high-rise apartment complex in China demonstrates the probable transmission of SARS-CoV-2 through fecal aerosols.
Single-dose nirsevimab successfully reduced rates of respiratory syncytial virus-associated lower respiratory infections and hospitalizations in pre-term infants.
Results are provided within 15 minutes and can be read directly from the testing card.
Current guidelines from Italy, the UK, and China do not focus on screening patients for anosmia as a potential symptom for COVID-19.
Researchers found limited clinical variability between PIV serotypes and substantial overlap in presenting signs and symptoms for PIV and other etiologies.
